French pharmaceutical giant Sanofi (NASDAQ: SNY) has signed a partnership deal with Cathay Capital, a global private equity and venture capital investment firm, at the 7th China International Import Expo (CIIE). This collaboration aims to deepen their existing long-term cooperation and serves as a positive step towards promoting Sino-French cooperation and the transformation and upgrading of China’s pharmaceutical industry.
Integrating Expertise to Unleash Chinese Innovation’s Global Potential
The partnership will integrate Sanofi’s industry expertise with Cathay Capital’s industry insights and cross-border investment experience. Together, they will provide comprehensive solutions across multiple dimensions, including research and development, clinical trials, market promotion, and regulatory compliance. This strategic alliance is designed to unleash the global potential of Chinese innovation in the pharmaceutical sector.- Flcube.com
